Global New Material, the global leader in the field of new consumable materials, specifically pearlescent materials, is currently in the…
Search Results: Frost (256)
As one of the seven strategic emerging industries in China and one of the ten key areas of development under…
China Risun Group Limited (China Risun, or the Group, HKG: 1907), a leading global integrated coke, coking chemicals and refined…
Revenue from Medical Services Surged 54.0% Revenue from Mainland Business Soared 52.5% Consolidates and Corporatizes Hong Kong Medical market Accelerates…
Offer Price Ranges Between HK$3.52 and HK$4.22 per Offer Share Raises Funds of HK$1,023.2 million to HK$1,226.6 million Introduces Two…
Avance Clinical, the leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient, announced…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, HKG: 2138), the largest non-hospital…
EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, SEHK stock code: 2138), the…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded…
Scivita Medical Technology Co., Ltd. (“civita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been…
The addition of the largest specialist medical imaging practice in Hong Kong to Black Spade’s investment portfolio highlights the family…
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa…
On February 26, 2020, Broad Homes (02163.HK) released its annual results announcement for 2020. In 2020, it achieved total revenue…
The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to…
Recently, promotion policies of prefabricated buildings were rolled out in succession, contributing to an on-going increase in scale of industrial…
Intco Medical (300677:CH), a leading Shenzhen listed personal protective equipment (PPE) provider, announced on 24 January a positive profit alert…
On February 1, China Medical System (0867.HK) announced that its subsidiary had acquired Luqa Ventures Co., Limited (“Luqa”), a dermatology specialty company. This…